Modular Medical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Modular Medical.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Modular Medical.

Recommendation Trends

Rating	Oct '23	Nov '23	Dec '23	Jan '24	Feb '24
Strong Buy	0	0	0	0	0
Buy	2	2	2	2	2
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bruce Jackson Benchmark	Benchmark	Buy Reiterates $5	Buy	Reiterates	$5	+358.72%	Mar 21, 2024
Steven Lichtman Oppenheimer	Oppenheimer	Buy Reiterates $3.5	Buy	Reiterates	$3.5	+221.10%	Sep 19, 2023
Bruce Jackson Benchmark	Benchmark	Buy Reiterates $5	Buy	Reiterates	$5	+358.72%	Jun 30, 2023
Steven Lichtman Oppenheimer	Oppenheimer	Buy Maintains $6 → $3.5	Buy	Maintains	$6 → $3.5	+221.10%	May 19, 2023
Bruce Jackson Benchmark	Benchmark	Buy Maintains $8 → $5	Buy	Maintains	$8 → $5	+358.72%	Jan 30, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.49

from -0.78

EPS Next Year

-0.40

from -0.49

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026
Revenue	-	3.26M
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.89	-1.19	-2.74	-1.15	-0.78	-0.49	-0.40
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	3.4M
Avg	n/a	3.3M
Low	n/a	3.1M

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.50	-0.41
Avg	-0.49	-0.40
Low	-0.47	-0.38

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.